Published in J Ethnopharmacol on September 21, 2011
Intersection of inflammation and herbal medicine in the treatment of osteoarthritis. Curr Rheumatol Rep (2012) 0.90
Nutraceuticals: potential for chondroprotection and molecular targeting of osteoarthritis. Int J Mol Sci (2013) 0.88
Brazilein from Caesalpinia sappan L. Antioxidant Inhibits Adipocyte Differentiation and Induces Apoptosis through Caspase-3 Activity and Anthelmintic Activities against Hymenolepis nana and Anisakis simplex. Evid Based Complement Alternat Med (2013) 0.88
Brazilin isolated from Caesalpinia sappan L. inhibits rheumatoid arthritis activity in a type-II collagen induced arthritis mouse model. BMC Complement Altern Med (2015) 0.81
Network pharmacology-based prediction of the multi-target capabilities of the compounds in Taohong Siwu decoction, and their application in osteoarthritis. Exp Ther Med (2013) 0.79
The immunosuppressant Protosappanin A diminished recipient T cell migration into allograft via inhibition of IP-10 in rat heart transplant. PLoS One (2014) 0.77
Sarcandra glabra Extract Reduces the Susceptibility and Severity of Influenza in Restraint-Stressed Mice. Evid Based Complement Alternat Med (2012) 0.77
Tamarind Seed (Tamarindus indica) Extract Ameliorates Adjuvant-Induced Arthritis via Regulating the Mediators of Cartilage/Bone Degeneration, Inflammation and Oxidative Stress. Sci Rep (2015) 0.76
Chondroprotective and anti-inflammatory effects of ChondroT, a new complex herbal medication. BMC Complement Altern Med (2016) 0.76
Brazilin isolated from the heartwood of Caesalpinia sappan L induces endothelium-dependent and -independent relaxation of rat aortic rings. Acta Pharmacol Sin (2015) 0.75
Anti-fibro-hepatocarcinogenic Chinese herbal medicines: A mechanistic overview. J Intercult Ethnopharmacol (2016) 0.75
Medicinal plants with potential anti-arthritic activity. J Intercult Ethnopharmacol (2015) 0.75
Melatonin inhibits Sirt1-dependent NAMPT and NFAT5 signaling in chondrocytes to attenuate osteoarthritis. Oncotarget (2017) 0.75
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol (2002) 82.19
Osteoarthritis. J Cell Physiol (2007) 5.55
Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis (2005) 3.25
MIQE précis: Practical implementation of minimum standard guidelines for fluorescence-based quantitative real-time PCR experiments. BMC Mol Biol (2010) 3.23
Cartilage homeostasis in health and rheumatic diseases. Arthritis Res Ther (2009) 2.44
Osteoarthritis, angiogenesis and inflammation. Rheumatology (Oxford) (2004) 2.33
Developments in the scientific understanding of osteoarthritis. Arthritis Res Ther (2009) 2.22
The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis. Arthritis Res Ther (2006) 1.93
Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence. Arthritis Res Ther (2006) 1.53
Prostaglandin E2 exerts catabolic effects in osteoarthritis cartilage: evidence for signaling via the EP4 receptor. J Immunol (2008) 1.45
Involvement of nuclear factor kappa B in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes. Arthritis Rheum (1997) 1.33
Nitric oxide in osteoarthritis. Osteoarthritis Cartilage (1999) 1.29
Selection of reliable reference genes for qPCR studies on chondroprotective action. BMC Mol Biol (2007) 1.16
Matrix metalloproteinases: pathways of induction by bioactive molecules. Heart Fail Rev (2004) 1.10
NF-kappaB and AP-1 are required for cyclo-oxygenase 2 gene expression in amnion epithelial cell line (WISH). Mol Hum Reprod (2000) 1.09
A review of the benefits and risks of nonsteroidal anti-inflammatory drugs in the management of mild-to-moderate osteoarthritis. Osteopath Med Prim Care (2009) 1.09
Targeting matrix metalloproteinases in inflammatory conditions. Curr Drug Targets (2009) 1.08
Evaluation of natural products on inhibition of inducible cyclooxygenase (COX-2) and nitric oxide synthase (iNOS) in cultured mouse macrophage cells. J Ethnopharmacol (2002) 1.07
The Ets transcription factor ESE-1 mediates induction of the COX-2 gene by LPS in monocytes. FEBS J (2005) 1.06
Nitric oxide in inflammation and pain associated with osteoarthritis. Arthritis Res Ther (2008) 1.06
Critical role of C/EBPdelta and C/EBPbeta factors in the stimulation of the cyclooxygenase-2 gene transcription by interleukin-1beta in articular chondrocytes. Eur J Biochem (2000) 1.05
Suppression of lipopolysaccharide-induced expression of inducible nitric oxide synthase by brazilin in RAW 264.7 macrophage cells. Eur J Pharmacol (2005) 1.02
Brazilein protects the brain against focal cerebral ischemia reperfusion injury correlating to inflammatory response suppression. Eur J Pharmacol (2006) 0.97
Antiinflammatory principles of Caesalpinia sappan wood and of Haematoxylon campechianum wood. Planta Med (1977) 0.95
Antioxidant activity of Caesalpinia sappan heartwood. Biol Pharm Bull (2003) 0.91
Lectin binding patterns reflect the phenotypic status of in vitro chondrocyte models. In Vitro Cell Dev Biol Anim (2009) 0.90
Phenotype-related differential alpha-2,6- or alpha-2,3-sialylation of glycoprotein N-glycans in human chondrocytes. Osteoarthritis Cartilage (2009) 0.90
Inhibition of matrix metalloproteinase-3 and -13 synthesis induced by IL-1beta in chondrocytes from mice lacking microsomal prostaglandin E synthase-1. J Immunol (2010) 0.89
In vitro anti-influenza viral activities of constituents from Caesalpinia sappan. Planta Med (2009) 0.89
Heme oxygenase-1 mediates the inhibitory actions of brazilin in RAW264.7 macrophages stimulated with lipopolysaccharide. J Ethnopharmacol (2008) 0.84
Anticonvulsant compounds from the wood of Caesalpinia sappan L. Arch Pharm Res (2000) 0.83
The antibacterial principle of Caesalpina sappan. Phytother Res (2004) 0.82
Anti-inflammatory constituents of Sappan Lignum. Biol Pharm Bull (2009) 0.82
In vitro study for inhibition of NO production about constituents of Sappan Lignum. Biol Pharm Bull (2007) 0.81
Retracted Caesalpinia sappan L. ameliorates hypercholesterolemia in C57BL/6 mice and suppresses inflammatory responses in human umbilical vein endothelial cells (HUVECs) by antioxidant mechanism. Immunopharmacol Immunotoxicol (2010) 0.80
Toxicity evaluation of sappan wood extract in rats. J Med Assoc Thai (2010) 0.80
Effects of brazilin on the production of fructose-2,6-bisphosphate in rat hepatocytes. J Ethnopharmacol (2005) 0.79
Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum (2012) 4.28
MIQE précis: Practical implementation of minimum standard guidelines for fluorescence-based quantitative real-time PCR experiments. BMC Mol Biol (2010) 3.23
The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop Relat Res (2004) 2.92
Inflammation in osteoarthritis. Curr Opin Rheumatol (2011) 2.72
Increased expression of the collagen receptor discoidin domain receptor 2 in articular cartilage as a key event in the pathogenesis of osteoarthritis. Arthritis Rheum (2007) 2.07
Intensification and stimulation therapy for human immunodeficiency virus type 1 reservoirs in infected persons receiving virally suppressive highly active antiretroviral therapy. J Infect Dis (2002) 1.91
NF-kappaB signaling: multiple angles to target OA. Curr Drug Targets (2010) 1.89
Roles of inflammatory and anabolic cytokines in cartilage metabolism: signals and multiple effectors converge upon MMP-13 regulation in osteoarthritis. Eur Cell Mater (2011) 1.84
Loss of methylation in CpG sites in the NF-κB enhancer elements of inducible nitric oxide synthase is responsible for gene induction in human articular chondrocytes. Arthritis Rheum (2013) 1.70
NF-kappa B-mediated repression of growth arrest- and DNA-damage-inducible proteins 45alpha and gamma is essential for cancer cell survival. Proc Natl Acad Sci U S A (2004) 1.66
Uptake of bone-seekers is solely associated with mineralisation! A study with 99mTc-MDP, 153Sm-EDTMP and 18F-fluoride on osteoblasts. Eur J Nucl Med Mol Imaging (2006) 1.65
The need for transparency and good practices in the qPCR literature. Nat Methods (2013) 1.58
Production of endogenous antibiotics in articular cartilage. Arthritis Rheum (2004) 1.55
Cementless total hip arthroplasty with a tapered, rectangular titanium stem and a threaded cup: a minimum ten-year follow-up. J Bone Joint Surg Am (2002) 1.55
Activation of the discoidin domain receptor 2 induces expression of matrix metalloproteinase 13 associated with osteoarthritis in mice. J Biol Chem (2004) 1.53
DNA demethylation at specific CpG sites in the IL1B promoter in response to inflammatory cytokines in human articular chondrocytes. Arthritis Rheum (2009) 1.46
CITED2-mediated regulation of MMP-1 and MMP-13 in human chondrocytes under flow shear. J Biol Chem (2003) 1.41
Cartilage oligomeric matrix protein/thrombospondin 5 supports chondrocyte attachment through interaction with integrins. J Biol Chem (2005) 1.37
A misplaced lncRNA causes brachydactyly in humans. J Clin Invest (2012) 1.36
Differential expression of GADD45beta in normal and osteoarthritic cartilage: potential role in homeostasis of articular chondrocytes. Arthritis Rheum (2008) 1.33
Homeostatic mechanisms in articular cartilage and role of inflammation in osteoarthritis. Curr Rheumatol Rep (2013) 1.31
A novel role for GADD45beta as a mediator of MMP-13 gene expression during chondrocyte terminal differentiation. J Biol Chem (2005) 1.30
Eating bone or adding it: the Wnt pathway decides. Nat Med (2007) 1.30
Divergent responses of chondrocytes and endothelial cells to shear stress: cross-talk among COX-2, the phase 2 response, and apoptosis. Proc Natl Acad Sci U S A (2005) 1.28
Vascular endothelial growth factor (VEGF) induces matrix metalloproteinase expression in immortalized chondrocytes. J Pathol (2004) 1.25
In vivo cyclic compression causes cartilage degeneration and subchondral bone changes in mouse tibiae. Arthritis Rheum (2013) 1.24
Egr-1 mediates transcriptional repression of COL2A1 promoter activity by interleukin-1beta. J Biol Chem (2003) 1.22
Regulated transcription of human matrix metalloproteinase 13 (MMP13) and interleukin-1β (IL1B) genes in chondrocytes depends on methylation of specific proximal promoter CpG sites. J Biol Chem (2013) 1.22
WISP3-dependent regulation of type II collagen and aggrecan production in chondrocytes. Arthritis Rheum (2004) 1.21
Cementless total hip arthroplasty with the rectangular titanium Zweymuller stem. A concise follow-up, at a minimum of fifteen years, of a previous report. J Bone Joint Surg Am (2006) 1.20
Up-regulation of microsomal prostaglandin E synthase 1 in osteoarthritic human cartilage: critical roles of the ERK-1/2 and p38 signaling pathways. Arthritis Rheum (2004) 1.16
Selection of reliable reference genes for qPCR studies on chondroprotective action. BMC Mol Biol (2007) 1.16
The epigenetic effect of glucosamine and a nuclear factor-kappa B (NF-kB) inhibitor on primary human chondrocytes--implications for osteoarthritis. Biochem Biophys Res Commun (2011) 1.15
A cis-regulatory site downregulates PTHLH in translocation t(8;12)(q13;p11.2) and leads to Brachydactyly Type E. Hum Mol Genet (2009) 1.13
Physiological loading of joints prevents cartilage degradation through CITED2. FASEB J (2010) 1.12
Bone and cartilage in osteoarthritis: is what's best for one good or bad for the other? Arthritis Res Ther (2010) 1.11
Divergent stress responses to IL-1beta, nitric oxide, and tunicamycin by chondrocytes. J Cell Physiol (2005) 1.08
Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1. Arthritis Rheum (2003) 1.08
ESE-1 is a potent repressor of type II collagen gene (COL2A1) transcription in human chondrocytes. J Cell Physiol (2008) 1.06
The Ets transcription factor ESE-1 mediates induction of the COX-2 gene by LPS in monocytes. FEBS J (2005) 1.06
The homeotic protein Six3 is a coactivator of the nuclear receptor NOR-1 and a corepressor of the fusion protein EWS/NOR-1 in human extraskeletal myxoid chondrosarcomas. Cancer Res (2003) 1.05
E74-like factor 3 (ELF3) impacts on matrix metalloproteinase 13 (MMP13) transcriptional control in articular chondrocytes under proinflammatory stress. J Biol Chem (2011) 1.04
Cells of the synovium in rheumatoid arthritis. Chondrocytes. Arthritis Res Ther (2007) 1.03
Suppressors of cytokine signalling (SOCS) are reduced in osteoarthritis. Biochem Biophys Res Commun (2011) 1.03
Endostatin/collagen XVIII--an inhibitor of angiogenesis--is expressed in cartilage and fibrocartilage. Matrix Biol (2004) 1.03
Differentiation regulates interleukin-1beta-induced cyclo-oxygenase-2 in human articular chondrocytes: role of p38 mitogen-activated protein kinase. Biochem J (2002) 1.02
GADD45beta enhances Col10a1 transcription via the MTK1/MKK3/6/p38 axis and activation of C/EBPbeta-TAD4 in terminally differentiating chondrocytes. J Biol Chem (2010) 1.02
Tissue engineering for total meniscal substitution: animal study in sheep model--results at 12 months. Tissue Eng Part A (2012) 1.01
ESE-1 is a novel transcriptional mediator of angiopoietin-1 expression in the setting of inflammation. J Biol Chem (2004) 1.01
Rhabdovirus-based vectors with human immunodeficiency virus type 1 (HIV-1) envelopes display HIV-1-like tropism and target human dendritic cells. J Virol (2002) 1.01
Transcriptional and post-transcriptional regulation of iNOS expression in human chondrocytes. Biochem Pharmacol (2009) 1.00
Proteomic analysis of synovial fluid from the osteoarthritic knee: comparison with transcriptome analyses of joint tissues. Arthritis Rheum (2013) 1.00
Chondrogenesis, joint formation, and articular cartilage regeneration. J Cell Biochem (2009) 1.00
Pulsed electromagnetic fields increased the anti-inflammatory effect of A₂A and A₃ adenosine receptors in human T/C-28a2 chondrocytes and hFOB 1.19 osteoblasts. PLoS One (2013) 1.00
Tissue engineering for total meniscal substitution: animal study in sheep model. Tissue Eng Part A (2008) 0.98
Isomeric analysis of oligomannosidic N-glycans and their dolichol-linked precursors. Glycobiology (2011) 0.97
Cementless total hip arthroplasty with the rectangular titanium Zweymüller stem: a concise follow-up, at a minimum of twenty years, of previous reports. J Bone Joint Surg Am (2012) 0.96
The TATA-containing core promoter of the type II collagen gene (COL2A1) is the target of interferon-gamma-mediated inhibition in human chondrocytes: requirement for Stat1 alpha, Jak1 and Jak2. Biochem J (2003) 0.96
Inhibitors of mitogen-activated protein kinases downregulate COX-2 expression in human chondrocytes. Mediators Inflamm (2005) 0.95
Involvement of p38 MAPK in regulation of MMP13 mRNA in chondrocytes in response to surviving stress to endoplasmic reticulum. Arch Oral Biol (2008) 0.95
IL-1beta and TNF-alpha alter the glycophenotype of primary human chondrocytes in vitro. Carbohydr Res (2010) 0.94
Residual HIV-1 disease in seminal cells of HIV-1-infected men on suppressive HAART: latency without on-going cellular infections. AIDS (2002) 0.94
Association of reduced type IX collagen gene expression in human osteoarthritic chondrocytes with epigenetic silencing by DNA hypermethylation. Arthritis Rheumatol (2014) 0.93
Preparation and first evaluation of [(18)F]FE@SUPPY: a new PET tracer for the adenosine A(3) receptor. Nucl Med Biol (2008) 0.93
Randomized, double-blind, placebo-controlled study of oral lactobacilli to improve the vaginal flora of postmenopausal women. Eur J Obstet Gynecol Reprod Biol (2008) 0.93
Human beta-defensin 3 mediates tissue remodeling processes in articular cartilage by increasing levels of metalloproteinases and reducing levels of their endogenous inhibitors. Arthritis Rheum (2005) 0.92
Development of tablets containing probiotics: Effects of formulation and processing parameters on bacterial viability. Int J Pharm (2008) 0.92
Reactive oxygen species induce expression of vascular endothelial growth factor in chondrocytes and human articular cartilage explants. Arthritis Res Ther (2006) 0.91
Prolonged application of high fluid shear to chondrocytes recapitulates gene expression profiles associated with osteoarthritis. PLoS One (2010) 0.91
Production of interleukin-1 receptor antagonist by human articular chondrocytes. Arthritis Res (2002) 0.90
Critical-size defect induces unicompartmental osteoarthritis in a stable ovine knee. J Orthop Res (2011) 0.90
C-28/I2 and T/C-28a2 chondrocytes as well as human primary articular chondrocytes express sex hormone and insulin receptors--Useful cells in study of cartilage metabolism. Ann Anat (2010) 0.90
Dual regulation of metalloproteinase expression in chondrocytes by Wnt-1-inducible signaling pathway protein 3/CCN6. Arthritis Rheum (2012) 0.89
Association of joint space narrowing with impairment of physical function and work ability in patients with early rheumatoid arthritis: protection beyond disease control by adalimumab plus methotrexate. Ann Rheum Dis (2012) 0.89
Long-term experience with Chiari's osteotomy. Clin Orthop Relat Res (2009) 0.89
A cementless hip system with a new surface for osseous integration. Int Orthop (2013) 0.88
Pre vivo, ex vivo and in vivo evaluations of [68Ga]-EDTMP. Nucl Med Biol (2007) 0.88
T cell-specific expression of the murine CD3delta promoter. J Biol Chem (2002) 0.88
Phenolic content and in vitro inhibitory effects on oxidation and protein glycation of some Thai medicinal plants. Pak J Pharm Sci (2010) 0.88
Senescence of chondrocytes in aging articular cartilage: GADD45β mediates p21 expression in association with C/EBPβ in senescence-accelerated mice. Pathol Res Pract (2011) 0.87
Relationship between cartilage stiffness and dGEMRIC index: correlation and prediction. J Orthop Res (2007) 0.87
ADAM17 controls endochondral ossification by regulating terminal differentiation of chondrocytes. Mol Cell Biol (2013) 0.87